Long term treatment with omalizumab in adolescent with refractory solar urticaria

• Principais autores: Mauro Iannelli (Autor), Stefano Passanisi (Autor), Giuseppe Crisafulli (Autor), Stefania Arasi (Autor), Lucia Caminiti (Autor), Giuseppina Zirilli (Autor), Giovanni B. Pajno (Autor)
• Formato: Livro
• Publicado em: BMC, 2021-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Solar urticaria represents an uncomfortable form of chronic inducible urticaria. First and second-line treatments are ineffective in some patients, leading to an impairment in their quality of life. Omalizumab represents a safe therapeutic option in case of refractory solar urtic...